Page last updated: 2024-11-05

tropicamide and Multiple Sclerosis

tropicamide has been researched along with Multiple Sclerosis in 1 studies

Tropicamide: One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grünberger, J1
Linzmayer, L1
Majda, EM1
Reitner, A1
Walter, H1

Other Studies

1 other study available for tropicamide and Multiple Sclerosis

ArticleYear
Pupillary dilatation test and Fourier analysis of pupillary oscillations in patients with multiple sclerosis.
    European archives of psychiatry and clinical neuroscience, 1996, Volume: 246, Issue:4

    Topics: Adult; Analysis of Variance; Female; Fourier Analysis; Humans; Male; Middle Aged; Multiple Sclerosis

1996